NIH-funded research R01 grant

Modeling how epigenetic mechanisms regulate gene expression in human cells

Official title: DMS/NIGMS 2: The mathematics of epigenetic regulation in human cells

Funded at University of Texas Dallas · NIH-11043483 · Data updated 2026-11-12

This study is exploring how tiny changes in our genes affect how they work in individual human cells, using special tools to help scientists understand these processes better, which could lead to new insights for people interested in genetics and health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Dallas
NIH-funded
Lab location1 site (Richardson, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2028
Funding year2024
Award (this year)$294,647
NIH project number1R01GM157608-01
Project IDNIH-11043483 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic conditions or diseases where epigenetic regulation plays a significant role.

Less likely to help

Patients with conditions unrelated to epigenetic mechanisms may not receive any benefit from this research.

What this research studies

This research investigates the complex interactions of epigenetic mechanisms that influence gene expression in human cells. By developing a theoretical and computational framework, the project aims to create predictive models that accurately represent these regulatory networks at the single-cell level. The approach involves assembling and integrating CRISPR-based epigenetic regulators into human cells, allowing researchers to gather extensive data on how these mechanisms operate. Through a combination of theoretical analysis and experimental validation, the study seeks to uncover general principles governing epigenetic regulation.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and manipulation of gene expression, potentially benefiting treatments for various genetic disorders.

How similar studies have gone: Previous research has shown promise in using CRISPR technology for gene regulation, indicating that this approach may yield valuable insights.

Where this research is happening

  • University of Texas Dallas
    Richardson, United States
    Active

Researchers

  • Principal investigator: Bleris, Leonidas — University of Texas Dallas
  • Study coordinator: Bleris, Leonidas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.